Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTSI, p16) in superficial bladder cancer detected by fluorescence in situ hybridization

Genes Chromosomes and Cancer

Volumn 19, Issue 2, 1997, Pages 84-89

  Balázs, Margit ^a,c   Carroll, Peter ^b   Kerschmann, Russell ^a   Sauter, Guido ^a,d   Waldman, Frederic M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR;

ADULT; AGED; BLADDER CANCER; CANCER GENETICS; CHROMOSOME 9; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; GENE DELETION; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL; REVIEW; SUPERFICIAL CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CHROMOSOME DELETION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; HOMOZYGOTE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; URINARY BLADDER NEOPLASMS;

EID: 0343923480     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199706)19:2<84::AID-GCC3>3.0.CO;2-W     Document Type: Review

References (27)

1. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D (1994a) Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-417.
2. Cairns P, Shaw ME, Knowles MA (1994b) Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9, Oncogene 8:1083-1085.
3. Devlin J, Keen AJ, Knowles MA (1994) Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA, Oncogene 9:2757-2760.
4. Dreyling MH, Bohlander SK, Adeyanju MO, Olopade OI (1995a) Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res 55:984-988.
5. Dreyling MH, Bohlander SK, Le Beau MM, Olopade OI (1995b) Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukcmias and other hematologic malignancies. Blood 86:1931-1938.
6. Fountain JW, Karayiorgou M, Ernstoff MS, Kirkwood JM, Vlock DR, Titus-Ernstoff L, Buchard B, Vijayasaradhi S, Houghton AN, Lahti J, Kidd VJ, Housman DE, Dracopoli NC (1994) Homozygous deletions within human chromosome band 9p21 in melanomas. Proc Natl Acad Sci USA 89:10557-10561.
7. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornour JM, Jones PA (1995a) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with silencing. Cancer Res 55:4531-4535.
8. Gonzalez-Zulueta M, Shibata AA, Ohneseit PF, Spruck CH 3rd, Busch C, Shamaa M, Elbaz M, Nicholas PW, Gonzalgo ML, Malmstrom P-U, Jones PA (1995b) High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamoua cell carcinoma of the bladder. JNCI 87:1383-1393.
9. Johnson GD, Davidson RS, McNamee KC, Russel G, Goodwin D, Holborrow EL (1982) Fading of immunofluoresccnce during microscopy: A study of the phenomenon and its remedy. J Immunol Methods 55:231-242.
10. Kallioniemi A, Kallioniemi O-P Peper J, Isola J, Waldman FM, Gray JW, Pinkel D (1994) Optimizing comparative genomic hybridiza- tion for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 10:231-243.
11. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
12. Keen AJ, Knowles MA (1994) Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene 9:2083-2088.
13. Liu Q, Neuhausnen S, McClurc M, Frye C, Weaver-Feldhaus J, Gruis NA, Eddington K, Allalunis-Turner MJ, Skolnick MH, Fujimura FK, Kamb A (1995) CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 10:1061-1067.
14. Matsumara K, Kallioniemi O, Kallioniemi A, Chen L, Smith H, Pinkel D, Gray J, Waldman FM (1992) Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Cancer Res 52:3474-3477.
15. Mostofi F (1973) Histopatological Typing of Urinary Bladder Tumors. Geneva: World Health Organization.
16. Nobori T, Miura K, Wu J, Lois A, Takayabashi K, Carson DA (1994) Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers, Nature 368:753-756.
17. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, CordonCardo C (1994) Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 54:2848-2851.
18. Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G, Reuter VE, Zhang ZF, Beach D, Cordon-Cardo C (1995) Deletion of the p16 and p15 genes in human bladder tumors. JNCI 87:1524-1529.
19. Packenham JP, Taylor JA, Anna CH, White CM, Devereux TR (1995) Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors. Mol Carcinogen 14:147-151.
20. Quelle, DE, Zindy F, Ashmun RA, Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
21. Sauter G, Haley J, Chew K, Kerschman R, Moore D, Carroll P, Moch H, Gudat F, Michatsh MJ, Waldman FM (1994) Epidermal growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer. Cancer Res 57:508-514.
22. Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch JM, Waldman FM (1995) Chromosome 9 loss detceted by fluorescence in situ hybridization in bladder cancer, Int J Cancer 64:99-103.
23. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4, Nature 366:704-707.
24. Stadler WM, Sherman J, Bohlander SK, Roulston D, Dreyling M, Rukstalis D, Olopade OI (1994) Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res 54:2060-2063.
25. Tsai YC, Nichols PW, Hiti AL, Williams Z, Skinner GD, Jones PA (1990) Allelic losses of chromosomes 9, 11, and 17 in bladder cancer, Cancer Res 50:44-47.
26. UICC TNM (1978) Classification of Malignant Tumours. Geneva: International Union Against Cancer.
27. Williamson MP, Elder PA, Shaw ME, Devlin J, Knowles MA (1995) p16 (CDKN2) is a major deletion target at 9p2l in bladder cancer. Hum Mol Genetics 4:1569-1577.